Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panhematin in Low or Intermediate-1 Risk MDS
NCT00467610Phase 2Terminated
- Sponsor
- Rush University Medical Center
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hemin in myelodysplastic syndrome (MDS), sponsored by Rush University Medical Center. Started May 2007; status: terminated.
02
Drugs
hemin
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00467610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467610.